Glenmark Life Sciences Ltd. - Research Center
543322 GLS Group (A) BSE data
Add to watchlist
| Results |
Quarterly
|
| Statement | |
| More |
Quarterly results in brief
(Rs crore)
| Sep' 24 | Jun' 24 | Mar' 24 | Dec' 23 | Sep' 23 | |
|---|---|---|---|---|---|
| Sales | 506.88 | 588.62 | 536.60 | 572.80 | 595.36 |
| Operating profit | 134.36 | 159.49 | 141.45 | 172.56 | 167.08 |
| Interest | 0.34 | 0.35 | 0.36 | 0.39 | 0.40 |
| Gross profit | 142.55 | 164.63 | 144.21 | 173.86 | 172.05 |
| EPS (Rs) | 7.78 | 9.10 | 7.99 | 9.69 | 9.69 |
Quarterly
results in details
| Sep' 24 | Jun' 24 | Mar' 24 | Dec' 23 | Sep' 23 | |
|---|---|---|---|---|---|
| Other income | 8.53 | 5.49 | 3.13 | 1.69 | 5.37 |
| Stock adjustment | -13.88 | 41.43 | -9.14 | -0.93 | 3.68 |
| Raw material | 239.08 | 246.36 | 247.84 | 243.13 | 269.40 |
| Power and fuel | - | - | - | - | - |
| Employee expenses | 62.44 | 56.84 | 72.26 | 71.05 | 66.71 |
| Excise | - | - | - | - | - |
| Admin and selling expenses | - | - | - | - | - |
| Research and development expenses | - | - | - | - | - |
| Expenses capitalised | - | - | - | - | - |
| Other expenses | 84.89 | 84.50 | 84.20 | 87.00 | 88.49 |
| Provisions made | - | - | - | - | - |
| Depreciation | 15.09 | 14.39 | 14.53 | 13.18 | 13.13 |
| Taxation | 32.14 | 38.76 | 31.74 | 41.92 | 40.19 |
| Net profit / loss | 95.32 | 111.48 | 97.94 | 118.77 | 118.74 |
| Extra ordinary item | - | - | - | - | - |
| Prior year adjustments | - | - | - | - | - |
| Equity capital | 24.51 | 24.51 | 24.51 | 24.51 | 24.51 |
| Equity dividend rate | - | - | - | - | - |
| Agg.of non-prom. shares (Lacs) | - | - | - | - | - |
| Agg.of non promotoholding (%) | - | - | - | - | - |
| OPM (%) | 26.51 | 27.09 | 26.36 | 30.12 | 28.06 |
| GPM (%) | 27.66 | 27.71 | 26.72 | 30.26 | 28.64 |
| NPM (%) | 18.49 | 18.76 | 18.15 | 20.67 | 19.77 |
© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis